Enliven Therapeutics, Inc. (ELVN)
46.97
+0.76
(+1.64%)
USD |
NASDAQ |
Oct 02, 16:00
46.97
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Market Cap : 3.441B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.441B |
| October 01, 2026 | 3.385B |
| September 30, 2026 | 3.358B |
| September 29, 2026 | 3.407B |
| September 28, 2026 | 3.370B |
| September 25, 2026 | 3.278B |
| September 24, 2026 | 3.309B |
| September 23, 2026 | 3.376B |
| September 22, 2026 | 3.530B |
| September 21, 2026 | 3.580B |
| September 18, 2026 | 3.622B |
| September 17, 2026 | 3.680B |
| September 16, 2026 | 3.598B |
| September 15, 2026 | 3.909B |
| September 14, 2026 | 3.987B |
| September 11, 2026 | 3.979B |
| September 10, 2026 | 4.119B |
| September 09, 2026 | 4.208B |
| September 08, 2026 | 4.349B |
| September 04, 2026 | 4.345B |
| September 03, 2026 | 4.369B |
| September 02, 2026 | 4.323B |
| September 01, 2026 | 4.238B |
| August 31, 2026 | 4.241B |
| August 28, 2026 | 4.238B |
| Date | Value |
|---|---|
| August 27, 2026 | 4.432B |
| August 26, 2026 | 4.458B |
| August 25, 2026 | 4.469B |
| August 24, 2026 | 4.479B |
| August 21, 2026 | 4.382B |
| August 20, 2026 | 4.316B |
| August 19, 2026 | 4.350B |
| August 18, 2026 | 4.400B |
| August 17, 2026 | 4.361B |
| August 14, 2026 | 4.309B |
| August 13, 2026 | 4.253B |
| August 12, 2026 | 4.243B |
| August 11, 2026 | 4.306B |
| August 10, 2026 | 4.353B |
| August 07, 2026 | 4.429B |
| August 06, 2026 | 4.415B |
| August 05, 2026 | 4.373B |
| August 04, 2026 | 4.476B |
| August 03, 2026 | 4.252B |
| July 31, 2026 | 3.337B |
| July 30, 2026 | 3.285B |
| July 29, 2026 | 3.225B |
| July 28, 2026 | 3.273B |
| July 27, 2026 | 3.211B |
| July 24, 2026 | 3.224B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Definium Therapeutics, Inc. | 5.025B |
| Cocrystal Pharma, Inc. | 15.79M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 483.87M |
| Fulcrum Therapeutics, Inc. | 281.49M |
Market Cap Related Metrics
| Price to Book Value | 3.844 |
| Price | 46.97 |
| Earnings Yield | -3.55% |